SCHEMBL235705

SCHEMBL235705

OCCCCNc1ccncn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.47
HTT P42858 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KDM4D Q6B0I6 1/20 0.43
HRH4 Q9H3N8 1/20 0.43
FYN P06241 1/20 0.43
HTR1A P08908 1/20 0.41
HTR1D P28221 1/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 2/20 0.38
KCNH3 Q9ULD8 1/20 0.37
CHRNB2 P17787 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL210080 0.98 NUDT1 (0.49) NUDT1SMN1; SMN2HTTCYP1A2CYP3A4
SCHEMBL18906038 0.95 NUDT1 (0.56) NUDT1SMN1; SMN2HTTCYP1A2CYP3A4
SCHEMBL30775333 0.95 NUDT1 (0.56) NUDT1SMN1; SMN2HTTCYP1A2CYP3A4
SCHEMBL32678784 0.87 SMN1; SMN2 (0.50) NUDT1SMN1; SMN2HTTCYP1A2CYP3A4
SCHEMBL32678782 0.87 SMN1; SMN2 (0.50) NUDT1SMN1; SMN2HTTCYP1A2CYP3A4
SCHEMBL32678778 0.87 SMN1; SMN2 (0.50) NUDT1SMN1; SMN2HTTCYP1A2CYP3A4
SCHEMBL22110996 0.87 SMN1; SMN2 (0.50) NUDT1SMN1; SMN2HTTCYP1A2CYP3A4
SCHEMBL3662937 0.82 DNM2 (0.50) SMN1; SMN2HTTCYP1A2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL8521658 0.81 SMN1; SMN2 (0.52) SMN1; SMN2HTTCYP1A2CYP3A4CYP2D6
SCHEMBL2638413 0.80 TLR8 (0.56) SMN1; SMN2HTTCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2400961-A1 DRUG COMBINATIONS CONTAINING PDE4 INHIBITORS AND NSAIDS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed